Effective 2nd August 2016, the Central Drugs Standard Control Organization (CDSCO) India released new circulars in relation to the conduct of clinical trials. These new circulars have modified the trial requirements for sponsors wishing to conduct clinical trials in India. Furthermore, the CDSCO have addressed matters that may assist in reducing clinical trial timelines and […]
Read More
High blood pressure, or hypertension, can be defined as the flow of blood through the arteries being pushed against the inside of the artery walls. The more pressure the blood exerts on the artery walls, the higher the blood pressure. Hypertension has been labelled the silent killer – as it rarely has symptoms. As such, […]
Read More
A recent article published in PharmAsia News highlighted the results of ground-breaking research, published in The New England Journal of Medicine (NEJM), that showed a lower dose of intravenous alteplase can reduce bleeds in the brain and improve survival rates in patients with acute ischemic stroke. While the results of ENCHANTED, a predominantly Asian study, […]
Read More
After careful selection and consideration, George Clinical’s (GC) Evon Hui of the Hong Kong office has accepted the position of Associate Director, Business Operations, East Asia (EA) and will be reporting directly to Marisa Petersen, Chief Executive Officer of GC. Evon joined GC in November 2012 as the Regional Clinical Operations Manager (COM) for the […]
Read More
From the 30th March – 1 April 2016, George Clinical will be exhibiting at the largest Bio exhibition in Asia – Bio Korea 2016, held in Seoul. BioKorea, established in 2006, has grown to be one of Asia’s premier events for global biotech industry. This year marks the 11th anniversary for this conference. BioKorea consists […]
Read More
The Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-pro t organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research […]
Read More
Philip Gregory of George Clinical – China, highlight South Korea’s capabilities in a three part series originally published on http://innovations.bbkworldwide.com/part-ii-insights-on-the-clinical-trial-landscape-of-south-korea. He provides insight on its recent clinical research developments that are driving innovation across the Asia-Pacific region. South Korea In comparison to Japan, South Korea has had a longer history of conducting global clinical trials. In fact, more than […]
Read More
Philip Gregory of George Clinical focuses on China, in a three part series originally published on http://innovations.bbkworldwide.com/part-iii-chinas-future-in-global-clinical-research that discusses developments in the clinical trial landscape of East Asia and Japan. Active international collaboration has facilitated the rise of the Asia-Pacific region in global clinical research. With the world’s largest population, China’s recent changes to their clinical trial processes and […]
Read More
Globally, there are millions of people that could benefit from an intensive lowering of blood pressure (BP). An individual with lower BP decreases their chances of suffering from any cardiovascular events such as: stroke, heart disease or heart attacks. A new study shows that lowering blood pressure to less than 140 mm Hg, the current […]
Read MoreSponsors are increasingly seeking emerging areas to conduct clinical trials for new patient pools and better recruitment. However, successful implementation of a global clinical trial in areas such as South East Asia requires operational strategies that circumvents the inherent diversity of these regions. In these regions, language, culture, infrastructure and resources are very different from […]
Read More
